Defects in p21(WAF1/CIP1), Rb, and c-myc signaling in phorbol ester- resistant cancer cells

Cancer Research

Volumn 57, Issue 2, 1997, Pages 320-325

  Blagosklonny, Mikhail V ^b   Prabhu, Nita S ^b   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; CARCINOGEN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MYC PROTEIN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; COLON CANCER; DOWN REGULATION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; ONCOGENE MYC; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR;

BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; DRUG RESISTANCE; FEMALE; GENES, MYC; HUMANS; MALE; NEOPLASM PROTEINS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030614514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marme, D., and Rapp, U. R. PKC-α activates Raf-1 by direct phosphorylation. Nature (Lond.), 364: 249-252, 1993,
2. Troppmair, J., Bruder, J. T., Munoz, H., Lloyd, P. A., Kyriakis, J., Banerjee, P., Avruch, J., and Rapp, U. R. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoyl-phorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem., 269: 7030-7035, 1994.
3. Seger, R., and Krebs, E. G. The MAPK signaling cascade. FASEB J., 9: 726-735, 1995.
4. Kelly, K., and Siebenlist, U. The regulation and expression of c-myc in normal and malignant cells. Ann. Rev. Immunol., 4: 317-338, 1986.
5. Nishizuka, Y. The family of protein kinase C for signal transduction. J. Am. Med. Assoc., 262: 1826-1833, 1989.
6. Collins, S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70: 1233-1244, 1987.
7. WAF1/CIP1 expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
8. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and El-Houseini, M. E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9: 3389-3396, 1994.
9. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
10. Liu, Y., Martindale, J. L., Gorospe, M., and Holbrook, N. J. Regulation of p21 WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res., 56: 31-35, 1996.
11. WAF1/CIP1 expression by p53-independent pathways. Oncogene. 12: 1557-1565, 1996.
12. Harper, J. W., Adami, G. R., Wei, N., Kayomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
13. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
14. Sherr, C. J., and Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
15. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
16. Blagosklonny, M. V., Alvarez, M., Fojo, A., and Neckers, L. M. Bcl-2 protein downregulation is not required for differentiation of multidrug resistant HL60 leukemia cells. Leukemia Res., 20: 101-107, 1996.
17. El-Deiry, W. S., Tokino, T., Veculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M. Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
18. WAF1/CIP1 deficient in PCNA interaction. Clin. Cancer Res, 2: 1221-1229, 1996.
19. Waf1 and p53 requires c-raf-1. Cancer Res., 55: 4623-4626, 1995.
20. Carroll, A. G., Voeller, H. J., Sugars, L., and Gelmann, E. P. p53 oncogene mutations in three human prostate cancer cell lines. Prostate, 23: 123-134, 1993.
21. Ragimov, N., Krauskopf, A., Navot, N., Rotter, V., Oren, M., and Aloni, Y. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene. 8: 1183-1193, 1993.
22. Gudas, J. M., Nguyen, H., Klein, R. C. Katayose, D., Seth, P., and Cowan, K. H. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res., 1: 71-80, 1995.
23. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
24. Sheikh, M. S., Li, X-S., Chen, J-C., Shao, Z-M., Ordonez, J. V., and Fontana, J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene. 9: 3407-343415, 1994.
25. Goodrich, D. W., and Lee, W-H. Abrogation by c-myc of G1 phase arrest by RB protein but not by p53. Nature (Lond.), 360: 177-179, 1992.
26. Hermeking, H., Funk, J. O., Reichert, M., Ellwart, J. W., and Eick, D. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21 Waf1/Cip1/SDI1. Oncogene, 11: 1409-1415, 1995.
27. Alexandrow, M. G., Kawabata, M., Aakre, M., and Moses, H. L. Overexpression of the c-myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 92: 3239-3243, 1995.
28. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., Fornace, A. J., Jr. A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.